Baseline characteristics of the patients in the trial
| Men (N=204) | Women (N=187) | |||||
| SOC (n=103) | NIT (n=101) | p Value | SOC (n=94) | NIT (n=93) | p Value | |
| Age, years | ||||||
| Mean | 29 | 28 | 0.4 | 25 | 24 | 0.3 |
| Range | 17–62 | 16–59 | 16–55 | 16–62 | ||
| Ethnicity | ||||||
| White British | 55 (54%) | 54 (53%) | 1.0 | 54 (57%) | 53 (57%) | 0.9 |
| Caribbean | 26 (25%) | 26 (26%) | 19 (20%) | 21 (23%) | ||
| Other | 22 (21%) | 21 (21%) | 21 (23%) | 19 (20%) | ||
| No of patients with previous attendance at this GUM clinic? | 38 (37%) | 49 (49%) | 0.09 | 38 (40%) | 41 (44%) | 0.6 |
| No of patients with previous check-up for STI? | 41 (40%) | 56 (55%) | 0.03 | 49 (52%) | 54 (58%) | 0.4 |
| No of patients previously diagnosed with STI? | 21 (20%) | 22 (22%) | 0.8 | 26 (28%) | 25 (27%) | 0.9 |
| Previous STI*: | ||||||
| Chlamydia | 18 (86%) | 19 (86%) | 0.8 | 22 (85%) | 20 (80%) | 0.8 |
| Gonorrhoea | 1 (5%) | 2 (9%) | 0.5 | 2 (8%) | 1 (4%) | 0.6 |
| Syphilis | 1 (5%) | 0 (–) | 0.3 | 0 (–) | 0 (–) | — |
| HIV | 1 (5%) | 0 (–) | 0.3 | 0 (–) | 0 (–) | — |
| Genital warts | 0 (–) | 0 (–) | – | 0 (–) | 1 (4%) | 0.3 |
| T vaginalis | 0 (–) | 0 (–) | – | 0 (–) | 1 (4%) | 0.3 |
| Other | 3 (14%) | 1 (5%) | 0.3 | 2 (8%) | 2 (8%) | 1.0 |
↵* Not mutually exclusive—patients could report more than one sexually transmitted infection (STI).
GUM, genitourinary medicine; NIT, non-invasive testing; SOC, standard of care.